v3.24.3
Balance Sheet Components
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Property and Equipment, Net
Property and equipment, net consisted of the following:
As of September 30, 2024As of December 31, 2023
Building and land$14,078 $11,728 
Leasehold improvements
824 802 
Computer hardware and software875 875 
Office and lab equipment11,362 9,961 
Furniture and fixtures1,793 1,550 
$28,932 $24,916 
Accumulated depreciation(11,201)(8,283)
17,731 16,633 
Equipment not yet in service544 558 
Property and equipment, net$18,276 $17,191 
Depreciation expense was $1,000 and $2,918 for the three and nine months ended September 30, 2024, respectively, and $857 and $2,421 for the three and nine months ended September 30, 2023, respectively.
Equipment not yet in service primarily consisted of lab equipment that had not been placed into service as of September 30, 2024 and December 31, 2023.
Other Non-current Assets
Other non-current assets consisted of the following:
As of September 30, 2024As of December 31, 2023
Operating lease right-of-use assets$28,909 $31,385 
Other3,048 2,400 
Other non-current assets$31,957 $33,785 
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
As of September 30, 2024As of December 31, 2023
Accrued employee compensation and benefits$15,881 $837 
Accrued clinical trial costs35,454 29,501 
Operating lease liabilities - current portion
3,676 3,308 
Other accrued expenses and other current liabilities8,509 6,200 
 Accrued expenses and other current liabilities$63,520 $39,846